The Guardian's interactive on Big Tech claims about AI and medical breakthroughs is valuable because it slows down a familiar promise. AI may help in medicine, but the path from impressive demos to better patient outcomes is long, regulated, and evidence-heavy.
Health care is one of the easiest places to overstate AI's impact. Better triage, imaging support, drug discovery, and administrative automation are all plausible, but each use case has different risks and proof requirements.
For readers, the useful stance is neither cynicism nor hype. The question is where AI is producing measurable clinical benefit, where it is reducing cost or burden, and where companies are using health language to sell a broader platform story.
Was this useful?
Help Pagish understand which AI stories are worth covering more deeply.
Tell Pagish if this story was useful.